IMMU-12. PHASE I/II TRIAL OF IMMUNOTHERAPY WITH FUSIONS OF DENDRITIC CELLS AND TUMOR CELLS FOR RELAPSED OR REFRACTORY BRAIN TUMORS IN CHILDREN AND YOUNG ADULTS

BACKGROUND/OBJECTIVES: Relapsed or refractory brain tumors in childhood continue to have a dismal prognosis in spite of intensive multidisciplinary treatment. Cancer immunotherapy is newly developed to be expected as next promising treatment for highly aggressive pediatric cancer. This trial was des...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaoka, Masayoshi, Akasaki, Yasuharu, Takei, Jun, Akiyama, Masaharu, Tasaki, Tetsunori, Ohashi, Toya, Ida, Hiroyuki, Yanagisawa, Takaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715224/
http://dx.doi.org/10.1093/neuonc/noaa222.368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715224/
http://dx.doi.org/10.1093/neuonc/noaa222.368

Ejemplares similares